Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Loebinger

Showing results (1-10 of 149) with videos related to

Pageof 15
Sort By:
The European Respiratory Journal|September 29, 2017
<i>Mycobacterium avium</i> complex infection: phenotypes and outcomesMichael R Loebinger
Chest|October 10, 2021
Nontuberculous Mycobacterial Pulmonary Disease: Clinical Epidemiologic Features, Risk Factors, and Diagnosis: The Nontuberculous Mycobacterial SeriesKartik Kumar, Michael R Loebinger
Archivos De Bronconeumologia|July 23, 2024
Non-Tuberculous Mycobacterial Pulmonary Disease-Where are we Now?Kartik Kumar, Michael R Loebinger
Chest|August 8, 2022
ResponseKartik Kumar, Michael R Loebinger
The European Respiratory Journal|May 2, 2015
Screening for latent tuberculosis before tumour necrosis factor antagonist therapyMichael R Loebinger, Anton Pozniak
Expert Opinion on Pharmacotherapy|November 27, 2007
Pharmacotherapy for bronchiectasisMichael R Loebinger, Robert Wilson
American Journal of Respiratory Cell and Molecular Biology|June 30, 2018
Reply to: Reduced IFN-γ in Patients with Pulmonary Nontuberculous Mycobacterial Disease: Potentially Multiple CausesSteven A Cowman, Michael R Loebinger
Chest|July 13, 2007
Stem cells for lung diseaseMichael R Loebinger, Sam M Janes
The European Respiratory Journal|January 18, 2020
Patient reported outcomes for non-tuberculous mycobacterial diseaseMichael R Loebinger, Surinder S Birring
Clinical Medicine (London, England)|July 13, 2012
Community acquired pneumonia: assessment and treatmentCaroline M Patterson, Michael R Loebinger
Pageof 15

Showing results (1-10 of 149) with videos related to

Sort By:
Pageof 15
The European Respiratory Journal|September 29, 2017
<i>Mycobacterium avium</i> complex infection: phenotypes and outcomesMichael R Loebinger
Chest|October 10, 2021
Nontuberculous Mycobacterial Pulmonary Disease: Clinical Epidemiologic Features, Risk Factors, and Diagnosis: The Nontuberculous Mycobacterial SeriesKartik Kumar, Michael R Loebinger
Archivos De Bronconeumologia|July 23, 2024
Non-Tuberculous Mycobacterial Pulmonary Disease-Where are we Now?Kartik Kumar, Michael R Loebinger
Chest|August 8, 2022
ResponseKartik Kumar, Michael R Loebinger
The European Respiratory Journal|May 2, 2015
Screening for latent tuberculosis before tumour necrosis factor antagonist therapyMichael R Loebinger, Anton Pozniak
Expert Opinion on Pharmacotherapy|November 27, 2007
Pharmacotherapy for bronchiectasisMichael R Loebinger, Robert Wilson
American Journal of Respiratory Cell and Molecular Biology|June 30, 2018
Reply to: Reduced IFN-γ in Patients with Pulmonary Nontuberculous Mycobacterial Disease: Potentially Multiple CausesSteven A Cowman, Michael R Loebinger
Chest|July 13, 2007
Stem cells for lung diseaseMichael R Loebinger, Sam M Janes
The European Respiratory Journal|January 18, 2020
Patient reported outcomes for non-tuberculous mycobacterial diseaseMichael R Loebinger, Surinder S Birring
Clinical Medicine (London, England)|July 13, 2012
Community acquired pneumonia: assessment and treatmentCaroline M Patterson, Michael R Loebinger
Pageof 15